Figure 1From: The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients Distribution of patients in three risk groups. a) According to local stage; b) According to gleason score; c) According to PSA levels; and d) According to E.U. A Guidelines and meeting all three criteria together.Back to article page